Skip to content

Real-Time Monitoring of Propofol Concentration in Exhaled breath based on UV-TOF-MS under targeted infusion of propofol: An Application Study

Real-Time Monitoring of Propofol Concentration in Exhaled breath based on UV-TOF-MS under targeted infusion of propofol: An Application Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083945
Enrollment
Unknown
Registered
2024-05-08
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who plan to undergo Elective surgery under general anesthesia and mechanical ventilation

Interventions

target-controlled infusion of Propofol under Marsh model :None
target-controlled infusion of Propofol under Schnider model :None
Propofol under closed-loop controlled infusion:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were as follows: patients undergoing elective surgeries under general anesthesia with an expected operation duration of =3 hours, encompassing but not limited to the following types: patients with breast lesions undergoing breast lesion resection, patients with thyroid tumors undergoing thyroid tumor excision, patients with lower limb surgeries such as high ligation and stripping for varicose veins, or patients with gallstones undergoing laparoscopic cholecystectomy, comprising a total of 54 cases; 18 = Age<65 years old; a gender ratio of 1:1 (male/female); body mass index (BMI) between 18.5 kg/m² and 30 kg/m²; and an American Society of Anesthesiologists (ASA) physical status classification of I or II.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with preoperative organic baseline diseases or dysfunction in major organs such as heart, liver, lung, kidney, or blood; those with a history of surgery or functional impairment; patients with a history of long-term use of psychotropic drugs, alcohol abuse, or allergies to soy, milk, or experimental drugs.

Design outcomes

Primary

MeasureTime frame
concentration of exhaled propofol ;

Secondary

MeasureTime frame
SBP, DBP, MAP;Bispectral index;heart rate;

Countries

China

Contacts

Public ContactZhang Wensheng

West China Hospital, Sichuan University

179704028@qq.com+86 178 4461 8151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026